EXO Biologics
Anne-Lien Thys currently serves as CFO at EXO Biologics since January 2023. Prior to this role, Anne-Lien held the position of Group Financial Controller at Hyloris Pharmaceuticals from September 2019 to December 2022, where responsibilities included finance management and investor relations.
This person is not in any teams
EXO Biologics
EXO Biologics is a Belgian clinical-stage biotechnology company focusing on researching and developing novel sub-cellular therapeutic candidates based on exosomes. Exo Biologics mission is to provide affordable and accessible exosomes therapies to patients with unmet medical needs. Exo Biologics has strong partnerships and influential networks for collaborating and researching new medical treatments, including research centers, public universities, and private partners.